Clinical Trial Update: Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating MRI-guided adaptive stereotactic radiotherapy to eliminate planning target volume margins in non-small cell lung cancer wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastasis
• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING